Approaches sponsors, CROs, and investigators can take from the DMD experience.
Michael G. Kelly, PhD
Advertisement
Chief Scientific Officer, CureDuchenne
Articles by Michael G. Kelly, PhD
Advertisement
Latest Updated Articles
Rare Disease Clinical Trials: Strategies Learned from Duchenne Muscular DystrophyPublished: October 14th 2022 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
